Johnson Chemical Pharmaceutical Works Co., Ltd.

Total Valuation

Johnson Chemical Pharmaceutical Works Co., Ltd. carries a market capitalization of 2.23B, placing it among publicly traded companies globally. Its enterprise value stands at 1.76B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Johnson Chemical Pharmaceutical Works Co., Ltd. currently has 45.38M shares outstanding.

Valuation Ratios

Johnson Chemical Pharmaceutical Works Co., Ltd. trades at a trailing price-to-earnings ratio of 49.51. The price-to-sales ratio is 4.65, and the price-to-book ratio stands at 5.23.

Enterprise Valuation

On an enterprise value basis, Johnson Chemical Pharmaceutical Works Co., Ltd. trades at an EV/EBITDA multiple of 24.05 and an EV/FCF ratio of 12.66. The EV/Sales ratio of 3.09 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.05 provides insight into valuation relative to core operating earnings.

Financial Position

Johnson Chemical Pharmaceutical Works Co., Ltd. maintains a current ratio of 3.79, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.27, indicating elevated leverage, while an interest coverage ratio of 19.52 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Johnson Chemical Pharmaceutical Works Co., Ltd. posts a return on equity of 10.23 and a return on invested capital of 3.22.

Taxes

Over the trailing twelve months, Johnson Chemical Pharmaceutical Works Co., Ltd. has paid 9.87M in income taxes, reflecting an effective tax rate of 15.58.

Stock Price Statistics

Johnson Chemical Pharmaceutical Works Co., Ltd.'s stock has declined approximately -24.57627% over the past 52 weeks. The 50-day moving average sits at 54.18, while the 200-day moving average is 59.34.

Income Statement

Over the trailing twelve months, Johnson Chemical Pharmaceutical Works Co., Ltd. generated 569.77M in revenue and converted that into 53.51M in net income, yielding earnings per share of 1.17. EBITDA reached 73.11M, while operating income came in at 73.11M.

Balance Sheet

Johnson Chemical Pharmaceutical Works Co., Ltd. holds 1.15B in cash and equivalents against 260.96M in total debt, resulting in a net debt position of -788.57M. Total book value stands at 506.89M, with working capital of 1.07B providing operational flexibility.

Cash Flow

Johnson Chemical Pharmaceutical Works Co., Ltd. produced 71.71M in operating cash flow over the past twelve months. After subtracting -64.05M in capital expenditures, free cash flow totaled 7.66M - equivalent to 0.17 per share.

Margins

Johnson Chemical Pharmaceutical Works Co., Ltd. operates with a gross margin of 40.08, reflecting its pricing power and cost economics. The operating margin of 12.83 and net profit margin of 9.39 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Johnson Chemical Pharmaceutical Works Co., Ltd.'s most recent stock split took place on June 12, 2023 with a 1000:1103 split ratio.

Scores

Johnson Chemical Pharmaceutical Works Co., Ltd. posts an Altman Z-Score of 5.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.